Cibus Past Earnings Performance

Past criteria checks 0/6

Cibus's earnings have been declining at an average annual rate of -56.1%, while the Biotechs industry saw earnings growing at 19.3% annually. Revenues have been declining at an average rate of 29.4% per year.

Key information

-56.1%

Earnings growth rate

31.9%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth rate-29.4%
Return on equity-441.9%
Net Margin-10,724.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Cibus: Expanding Opportunities And Growing Accessible Market

Jan 12

Is Cibus, Inc. (NASDAQ:CBUS) Trading At A 44% Discount?

Oct 19
Is Cibus, Inc. (NASDAQ:CBUS) Trading At A 44% Discount?

Does Cibus (NASDAQ:CBUS) Have A Healthy Balance Sheet?

Sep 07
Does Cibus (NASDAQ:CBUS) Have A Healthy Balance Sheet?

Calyxt signs agreement with Evologic to scale production of plant-based ingredients

Oct 07

Calyxt exploring strategic alternatives

Sep 22

Calyxt Switches Gears Again, But The Cash Clock Keeps Ticking Down

Apr 01

Revenue & Expenses Breakdown

How Cibus makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:CBUS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244-4452547
30 Jun 243-2922651
31 Mar 242-2862244
31 Dec 232-2681636
30 Sep 231-531729
30 Jun 230-331115
31 Mar 230-171010
31 Dec 220-171112
30 Sep 222-211412
30 Jun 2210-221412
31 Mar 2222-251411
31 Dec 2126-291511
30 Sep 2138-361612
30 Jun 2135-381711
31 Mar 2126-441911
31 Dec 2024-452111
30 Sep 2014-442311
30 Jun 2011-452512
31 Mar 2010-432612
31 Dec 197-402512
30 Sep 194-362511
30 Jun 191-332311
31 Mar 190-312012
31 Dec 180-281810
30 Sep 180-261610
30 Jun 180-321913
31 Mar 180-281611
31 Dec 171-261512
30 Sep 170-241311
30 Jun 170-1386
31 Mar 170-1276
31 Dec 160-1276
31 Dec 151-643

Quality Earnings: CBUS is currently unprofitable.

Growing Profit Margin: CBUS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CBUS is unprofitable, and losses have increased over the past 5 years at a rate of 56.1% per year.

Accelerating Growth: Unable to compare CBUS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CBUS is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (16.6%).


Return on Equity

High ROE: CBUS has a negative Return on Equity (-441.85%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:31
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cibus, Inc. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew VeneziaAlliance Global Partners
Donald McLeeBerenberg
Kenneth ZaslowBMO Capital Markets Equity Research